THERAPEUTIC SOLUTIONS INTL INC News

THERAPEUTIC SOLUTIONS INTL INC | 10-Q: Quarterly report

SEC announcementMay 31 02:53 · Announcements

Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board

Therapeutic Solutions International Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company Therapeutic Solutions International, Inc. (TSOI)

BusinesswireMay 9 21:00

Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy

Yahoo FinanceJan 16 22:00

Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using MRNA

Clinical Stage Cell Therapy Contributes to Personalized Immunotherapy Revolution Therapeutic Solutions International, Inc. (TSOI), announced today the publication of a peer-reviewed paper entitled "Advancing

BusinesswireNov 20, 2023 22:00

Res Nova Biologics Announces First Cancer Patient Treated With FloraStilbene

Therapeutic Solutions International Immuno-Oncology Subsidiary Makes Abortion Pill-Based Drug Available by Prescription through Cure Stat Rx Compounding Pharmacy Therapeutic Solutions International, Inc. (TSOI),

BusinesswireOct 20, 2023 21:00

Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils

Therapeutic Solutions International, Inc. (TSOI) announced today a patent filing covering the unanticipated finding that neutrophils, a type of white blood cell, when manufactured in a specific manner, are capable of

BusinesswireSep 29, 2023 21:00

Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board

Appointment of Dr. Navneet Boddu to Expand Patient Access to Stem Cells in FDA Compliant Manner Therapeutic Solutions International, Inc. (TSOI), announced today the appointment of internationally renowned stem cell

BusinesswireSep 18, 2023 21:00

Therapeutic Solutions International Subsidiary Discloses Potential Solution to Immunotherapy Resistance in Cancer by "Healing Tumor" Before Killing It

Stem Cell Modification of Cancer Microenvironment Shown to Increase Ability of Immune System to Stop Breast Cancer Therapeutic Solutions International, Inc. (TSOI) announced today new data and a patent filing from its

BusinesswireSep 15, 2023 21:00

Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia

Company Leverages CTE Investigational New Drug Disease Filing and Clinical Experiences Under Right to Try to Create Multidisciplinary Protocol to Address Common form of Dementia Therapeutic Solutions International,

BusinesswireSep 11, 2023 21:00

Therapeutic Solutions International Subsidiary Allogen Biologics Inc. Successfully Manufactures JadiCell Master Cell Bank to Provide Cells for Right to Try Use and Phase III ARDS Clinical Trial

Clinical Stage Cell Therapy Company Achieves Significant Production Milestone Therapeutic Solutions International, Inc. (TSOI), reported today successfully generation of a quality control tested Master Cell Bank

BusinesswireAug 16, 2023 20:39

Therapeutic Solutions International Files for Orphan Drug Designation Using JadiCell Adult Universal Donor Stem Cells for Treatment of Acute Respiratory Distress Syndrome

Clinical Stage Biotech Company Leverages Existing Clinical Data and Phase III Clearance to Accelerate Treatment of Fatal Lung Condition Therapeutic Solutions International (TSOI) announced today filing with the FDA

BusinesswireJun 26, 2023 21:00

Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses

ValloVax Cancer Endothelial Stem Cell Technology Repositioned to Overcome Limitations on Multibillion Dollar Cancer Immunotherapy Market Therapeutic Solutions International (TSOI) announced today its Spin-Off Company,

BusinesswireMay 22, 2023 21:00

Therapeutic Solutions International Spin-Off Res Nova Bio Partners With Cure Stat Rx to Manufacture First in Class Breast Cancer Immunotherapy Product FloraStilbene

Clinical Stage Biotech Company Partners with Premier Compounding Pharmacy to Provide Doses for IRB Cleared Phase I/II Clinical Trial Therapeutic Solutions International (TSOI) spin-off Res Nova Bio announced today a

BusinesswireMay 15, 2023 21:00

Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc.

Company Using the Immune System as a "Stethoscope for the Brain" to Identify Individuals with Propensity for Suicide Aims to Revolutionize Practice of Psychiatry Therapeutic Solutions International (TSOI) Spin Off

BusinesswireMar 27, 2023 21:03

Therapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal Ideations

Biotech Company Leverages Previous Clinical Trial Blood Based Biomarker Data to Create Point of Care Psychiatric Assessment Tool Therapeutic Solutions International (TSOI) announced today its Spin Off Company, Campbell

BusinesswireMar 20, 2023 21:03

Therapeutic Solutions International Launches Veltmeyer Institute for Advanced Biologics

FDA Phase III Stem Cell Company Offers End Stage Patients Access to FDA Cleared Clinical Trial Stem Cells Therapeutic Solutions International (TSOI) announced the launching of the Veltmeyer Institute for Advanced

BusinesswireFeb 21, 2023 22:07

Therapeutic Solutions International Identifies Novel Cellular Marker Associated With Therapeutic Response to JadiCell Stem Cell Treatment

New Finding May Facilitate Personalized Stem Cell Therapy Therapeutic Solutions International (TSOI) announced today identification and patent filing of a previously unexpected discovery that responsiveness to JadiCell

BusinesswireJan 9, 2023 22:06

Therapeutic Solutions Develops Gene Silencing Therapy for Acute Respiratory Distress Syndrome

Therapeutic Solutions (OTCPK:TSOI) announced on Monday data and filing of a patent covering the use of "gene silencing" to treat Acute Respiratory Distress Syndrome (ARDS). The Company currently is ru

Seeking AlphaAug 29, 2022 21:56

Therapeutic Solutions to expand patient access to its JadiCell stem cell therapy for COVID

Therapeutic Solutions International (OTCPK:TSOI) on Monday said it had been granted an emergency investigational new drug (IND) clearance by the U.S. FDA for expanded patient access to its JadiCell st

Seeking AlphaJul 18, 2022 23:02

Therapeutic Solutions International Granted Emergency IND by FDA for Expanded Patient Access to JadiCell™ Universal Donor Stem Cell for COVID-19 ARDS Outside of Ongoing Phase III Clinical Trial

Company Responds to Rapidly Growing COVID-19 Cases by Increasing Mechanisms to Make Lung Healing Cells Available Therapeutic Solutions International announced today granting of Emergency IND # 28685 and a "May Proceed Notification" from the Food and

BusinessWireJul 18, 2022 21:05